Physician profile
Barry Ettinger
NPI 1245524933
$1,209.93
in general payments reported to CMS, 2019-2025
20 companies · $102 in 2025
The $102 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $133 · 2021: $128 · 2022: $347 · 2023: $158 · 2024: $131 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $391.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $516.52 | 2019-2025 | Caldolor |
| Merck Sharp & Dohme LLC | $122.69 | 2019-2025 | Bridion |
| Chiesi USA, INC. | $85.09 | 2020-2022 | |
| Avanos Medical | $66.70 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $65.38 | 2019-2023 | Plenvu |
| Takeda Pharmaceuticals U.S.A., INC. | $49.16 | 2023-2025 | Eohilia, Entyvio |
| Csl Behring | $48.15 | 2020-2022 | |
| Heron Therapeutics, INC. | $47.97 | 2022 | |
| Werfen USA LLC | $38.00 | 2022 | |
| Ambu INC. | $21.37 | 2020 | |
| Abbvie INC. | $19.00 | 2024 | |
| Ardelyx, INC. | $17.81 | 2025 | Ibsrela |
| Lilly USA, LLC | $16.92 | 2024 | Omvoh |
| Aimmune Therapeutics, INC. | $15.17 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $14.96 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $14.71 | 2024 | Iovera, Exparel |
| Trevena, INC. | $14.69 | 2021 | |
| Mallinckrodt Hospital Products INC. | $12.03 | 2020 | |
| Acelrx Pharmaceuticals, INC. | $11.95 | 2019 | |
| Redhill Biopharma INC. | $11.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Ettinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.